MCB 295 Spring 2007
Feb. 1
Abby Dernburg – Academia/Govt. Lab: Assistant Prof. in Residence of Cell and Developmental Biology, UC Berkeley; Senior Scientist, Life Sciences Division, Lawrence Berkeley National Lab
Jared Young – Academia: Assistant Professor of Biology, Mills College
Feb. 8
Sean George – Biotech/Consulting: Vice President of Life Science Research, Affymetrix, previously Invitrogen and McKinsey & Company
Katie Swango – Govt. Lab: Criminalist, Dept. of Justice DNA Crime Laboratory
Feb. 15
Robert Tijan – Academia: HHMI, Professor of Biochemistry and Molecular Biology, UC Berkeley
Ken Bagchi – Government: Special Agent, Federal Bureau of Investigation
Feb. 22
Cyrus Harmon – Entrepreneurship in Biotech: Previous Founder & CEO of Neomorphic, Previous Vice President of Computational Genomics, Affymetrix.
David Duhl – Biotech: Director Cell Biology/Biochemistry and Project Leader Oncology,
Novartis, previously Chiron Corporation President: (Rik Kretzinger: Sr. Recruiter for Novartis)
March 1
Irvine Mettler – Patent Law: Senior Licensing Officer, UC Berkeley
Chris Ullsperger – Patent Law: Associate, Townsend & Townsend & Crew LLP
March 8
Jennifer Kahn – Science Journalism: Contributing Editor, Wired Magazine
Howard Schachman –Public Policy: Professor of Biochemistry and Molecular Biology, UC Berkeley, NIH
March 15
Michael Dybbs – Consulting: Boston Consulting Group
Fyodor Urnov – Biotech: Scientist, Sangamo Biosciences, Inc.
March 22
Kristin Cobb – Science Writing: Clinical Assistant Professor, Dept. of Health Research, and Policy, Stanford University
Mike Eisen – Entrepreneurship in Science Journals/Govt. Lab/Academia: PLoS Co-founder; Scientist, Life Sciences Division, Lawrence Berkeley National Lab; Adjunct Assistant Professor of Genetics and Development, UC Berkeley
March 29: No Class; Spring Break
April 5
Ellen Filvaroff – Biotech: Senior Scientist of Molecular Oncology, Genentech
April 12
Bob Saul – Entrepreneurship in Biotech: founder and president, Polymorphic DNA Technologies, Inc., previously founder and president, Operon Technologies, Inc.
Robert Kuhn – Business Strategy in Biotech: Chief Technical Officer, Aerovance Inc.
April 19
To be announced
April 26
To be announced
Comments (0)
You don't have permission to comment on this page.